Citi Upgrades Abbvie (ABBV) to Neutral
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $253.35 +4.20%
Rating Summary:
26 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
26 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
Citi upgraded Abbvie (NYSE: ABBV) from Sell to Neutral with a price target of $60.00.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $55.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
- JPMorgan Upgrades Fubon Financial Holding (2881:TT) (FUISF) to Overweight
- Health Canada approves AbbVie's Boey for frown line treatment
Create E-mail Alert Related Categories
UpgradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
